Resveratrol: Inhibitory Effects on Metastatic Cell Behaviors and Voltage-Gated Na⁺ Channel Activity in Rat Prostate Cancer In Vitro

REFERENCES

• Siegel R, Naishadham D, and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62, 10–29, 2012.
   PubMed Web of Science ®Google Scholar
• Davies NJ, Batehup L, and Thomas R: The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 105, S52–S73, 2011.
   PubMed Web of Science ®Google Scholar
• Dennis T, Fanous M, and Mousa S: Natural products for chemopreventive and adjunctive therapy in oncologic disease. Nutr Cancer 61, 587–597, 2009.
   PubMed Web of Science ®Google Scholar
• Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nature Rev Drug Discovery 5, 493–506, 2006.
   PubMed Web of Science ®Google Scholar
• Renaud S and de Lorgeril M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523–1526, 1992.
   PubMed Web of Science ®Google Scholar
• Aziz MH, Reagan-Shaw S, Wu JQ, Longley BJ, and Ahmad N: Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J 19, 1193–1211, 2005.
   PubMed Web of Science ®Google Scholar
• Marinova EM, Yanishlieva NV, and Totseva IR: Anti-oxidant activity and mechanism of action of trans-resveratrol in different lipid systems. Int J Food Sci Tech 37, 145–152, 2002.
   Web of Science ®Google Scholar
• Naderali EK, Doyle PJ, and Williams G: Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin Sci 98, 537–543, 2000.
   PubMed Web of Science ®Google Scholar
• Jang MS, Cai L, Udeani GO, Slowing KV, Thomas CF, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218–220, 1997.
   PubMed Web of Science ®Google Scholar
• Saleh MC, Connell BJ, and Saleh TM: Resveratrol preconditioning induces cellular stress proteins and is mediated via NMDA and estrogen receptors. Neurosci 166, 445–454, 2010.
   PubMed Web of Science ®Google Scholar
• Tang F-Y, Su Y-C, Chen N-C, Hsieh H-S, and Chen K-S: Resveratrol inhibits migration and invasion of human breast cancer cells. Molec Nutrition Food Res 52, 683–691, 2008.
   PubMed Web of Science ®Google Scholar
• Kim HI, Kim TH, and Song JH: Resveratrol inhibits Na+ currents in rat dorsal root ganglion neurons. Brain Res 1045, 134–141, 2005.
   PubMed Web of Science ®Google Scholar
• Wallace CHR, Baczko I, Jones L, Fercho M, and Light PE: Inhibition of cardiac voltage-gated sodium channels by grape polyphenols. Br J Pharmacol 149, 657–665, 2006.
   PubMed Web of Science ®Google Scholar
• Qian C, Ma J, Zhang P, Luo A, Wang C, et al.: Resveratrol attenuates the Na+-dependent intracellular Ca2+ overload by inhibiting H2O2-induced increase in late sodium current in ventricular myocytes. PLOS ONE 7, e51358, 2012.
   PubMed Web of Science ®Google Scholar
• Diss JKJ, Archer SN, Hirano J, Fraser SP, and Djamgoz MBA: Expression profiles of voltage-gated Na+ channel α-subunit genes in rat and human prostate cancer cell lines. The Prostate 48, 1–14, 2001.
   PubMed Web of Science ®Google Scholar
• Diss JKJ, Stewart D, Pani F, Foster CS, Walker MM, et al.: A potential novel marker for human prostate cancer progression: voltage-gated Na+ channel expression in vivo. Prostate Cancer Prostatic Dis 8, 266–273, 2005.
   PubMed Web of Science ®Google Scholar
• Grimes JA, Fraser SP, Stephens GJ, Downing JEG, Laniado ME, et al.: Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Letts 369, 290–294, 1995.
   PubMed Web of Science ®Google Scholar
• Laniado ME, Lalani E-N, Fraser SP, Grimes, JA, Bhangal G, et al.: Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasiveness in vitro. Am J Pathol 150, 1213–1221, 1997.
   PubMed Web of Science ®Google Scholar
• Fraser SP, Salvador V, Manning E, Mizal J, Altun S, et al.: Contribution of functional voltage-gated Na+ channel expression to cell behaviours involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. J Cell Physiol 195, 479–487, 2003.
   PubMed Web of Science ®Google Scholar
• Mycielska ME, Fraser SP, Szatkowski M, and Djamgoz MBA: Contribution of functional voltage-gated Na+ channel expression to cell behaviours involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity. J Cell Physiol 195, 461–469, 2003.
   PubMed Web of Science ®Google Scholar
• Palmer CP, Mycielska ME, Burcu H, Osman K, Collins T, et al.: Single cell adhesion measuring apparatus (SCAMA): application to cancer cell lines of different metastatic potential and voltage-gated Na+ channel expression. Eur Biophys J 37, 359–368, 2008.
   PubMed Web of Science ®Google Scholar
• Fraser SP, Ding Y, Liu A, Foster CS, and Djamgoz MBA: Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line. Cell Tissue Res 295, 505–512, 1999.
   PubMed Web of Science ®Google Scholar
• Fraser SP, Grimes JA, Diss JKJ, Stewart D, Dolly JO, et al.: Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation. Pflugers Arch 446, 559–571, 2003.
   PubMed Web of Science ®Google Scholar
• Laniado ME, Fraser SP, and Djamgoz MBA: Voltage-gated K+ channel activity in human prostate cancer cell lines of markedly different metastatic potential: Distinguishing characteristics of PC-3 and LNCaP cells. The Prostate 46, 262–274, 2001.
   PubMed Web of Science ®Google Scholar
• Fraser SP, Diss JKJ, Chioni A-M, Mycielska ME, Pan H, et al.: A novel voltage-gated sodium channel neonatal splice form promotes invasiveness of human breast cancer. Clin Cancer Res 11, 5381–5389, 2005.
   PubMed Web of Science ®Google Scholar
• Grimes JA and Djamgoz MBA: Electrophysiological characterization of voltage-gated Na+ current expressed in the highly metastatic Mat-LyLu cell line of rat prostate cancer. J Cell Physiol 175, 50–58, 1998.
   PubMed Web of Science ®Google Scholar
• Barber MJ, Starmer CF, and Grant AO: Blockade of cardiac sodium-channels by amitriptyline and diphenylhydantoin: evidence for two use-dependent binding-sites. Circulation Res 69, 677–696, 1991.
   PubMed Web of Science ®Google Scholar
• Wendt DJ, Starmer, CF, and Grant AO: Kinetics of interaction of the lidocaine metabolite glycylxylidide with the cardiac sodium channel. Additive blockade with lidocaine. Circulation Res 70, 254–1273, 1992.
   Web of Science ®Google Scholar
• Haeseler G, Piepenbrink A, Bufler J, Dengler R, Aronson JK, et al.: Structural requirements for voltage-dependent block of muscle sodium channels by phenol derivatives. Br J Pharmacol 132, 1916–1924, 2001.
   PubMed Web of Science ®Google Scholar
• Ragsdale DS, McPhee JC, Scheuer T, and Catterall WA: Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science 265, 1724–1728, 1994.
   PubMed Web of Science ®Google Scholar
• Yarov-Yarovoy V, McPhee JC, Idsvoog D, Pate C, Scheuer T, et al.: Role of amino acid residues in transmembrane segments IS6 and IIS6 of the Na+ channel alpha subunit in voltage-dependent gating and drug block. J Biol Chem 277, 35393–35401, 2002.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al.: Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 24, 2783–2840, 2004.
   PubMed Web of Science ®Google Scholar
• Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, and Castellón EA: Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl 28, 282–293, 2007.
   PubMed Web of Science ®Google Scholar
• Morris GZ, Williams RL, Elliott MS, and Beebe SJ: Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. The Prostate 52, 319–329, 2002.
   PubMed Web of Science ®Google Scholar
• Chang, H-T, Chou, C-T, Chen, I-L, Liang, W-Z, Kuo, DH, et al.: Mechanisms of resveratrol-induced changes in [Ca2+](i) and cell viability in PC3 human prostate cancer cells. J Recept Signal Transduct Res 33, 298–303, 2013.
   PubMed Web of Science ®Google Scholar
• Joe AK, Liu H, Suzui M, Vural ME, Xiao DH, et al.: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8, 893–903, 2002.
   PubMed Web of Science ®Google Scholar
• Kampa M, Hatzoglou A, and Notas G: Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer 37, 223–233, 2000.
   PubMed Web of Science ®Google Scholar
• Hseih T-C and Wu JM: Differential effects on growth, cell cycle arrest, and induction of apoptosis by Resveratrol in human prostate cancer cell lines. Exper Cell Res 249, 109–115, 1999.
   PubMed Web of Science ®Google Scholar
• Kuwajerwala N, Cifuentes E, Gautam S, Menon M, Barrack ER, et al.: Resveratrol induces prostate cancer cell entry into S phase and inhibits DNA synthesis. Cancer Res 62, 2488–2492, 2002.
   PubMed Web of Science ®Google Scholar
• Weng C-J and Yen G.-C: Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38, 76–87, 2012.
   PubMed Web of Science ®Google Scholar
• Fraser SP, Ozerlat-Gunduz I, Diss JKJ, Onkal R, and Djamgoz MBA: Estrogen and non-genomic upregulation of voltage-gated Na+ channel activity in MDA-MB-231 human breast cancer cells: Role in adhesion. J Cell Physiol 224, 527–539, 2010.
   PubMed Web of Science ®Google Scholar
• Ferrero ME, Bertelli AE, Fulgenzi A, Pellegatta F, Corsi MM, et al.: Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr 68, 1208–1214, 1998.
   PubMed Web of Science ®Google Scholar
• Brackenbury WJ and Djamgoz MBA: Activity-dependent regulation of voltage-gated Na+ channel expression in Mat-LyLu rat prostate cancer cell line. J Physiol-London 573, 343–356, 2006.
   PubMed Web of Science ®Google Scholar
• Campbell TM, Main MJ, and Fitzgerald EM: Functional expression of the voltage-gated sodium channel, Nav1.7, underlies epidermal growth factor-mediated invasion in human non-small cell lung cancer cells. J Cell Sci 126, 4939–4949, 2013.
   PubMed Web of Science ®Google Scholar
• Fraser SP, Özerlat-Gunduz I, Brackenbury WJ, Fitzgerald EM, Campbell TM, et al.: Regulation of voltage-gated sodium channel expression in cancer: Hormones, growth factors and auto-regulation. Philos Trans R Soc Lond B Biol Sci 369, 20130105, 2014.
   PubMed Web of Science ®Google Scholar
• Thuc LC, Teshima Y, Takahashi N, Nishio S, and Fukui A: Inhibition of Na⁺-H⁺ exchange as a mechanism of rapid cardioprotection by resveratrol. Br J Pharmacol 166, 1745–1755, 2012.
   PubMed Web of Science ®Google Scholar
• Brisson L, Gillet L, Calaghan S, Besson P, Le Guennec JY, et al.: Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H+ efflux in caveolae. Oncogene 30, 2070–2076, 2011.
   PubMed Web of Science ®Google Scholar
• Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, et al.: Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 49, 495–504, 2005.
   PubMed Web of Science ®Google Scholar
• van Ginkel PR, Sareen D, Subramanian L, Walker Q, Darjatmoko SR, et al.: Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 13, 5162–5169, 2007.
   PubMed Web of Science ®Google Scholar
• Wang TTY, Hudson TS, Wang TC, Remsberg CM, Davies NM, et al.: Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 29, 2001–2010, 2008.
   PubMed Web of Science ®Google Scholar
• Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, et al.: Clinical trials of resveratrol. Ann NY Acad Sci 1215, 161–169, 2011.
   PubMed Web of Science ®Google Scholar
• Fraser SP and Pardo LA: Ion channels: functional expression and therapeutic potential in cancer. EMBO Reports 9, 512–515, 2008.
   PubMed Web of Science ®Google Scholar
• Pedersen SF and Stock C: Ion channels and transporters in cancer: Pathophysiology, regulation and clinical potential. Cancer Res 73, 1658–1661, 2013.
   PubMed Web of Science ®Google Scholar
• Djamgoz MBA and Onkal R: Persistent current blockers of voltage-gated sodium channels: A clinical opportunity for controlling metastatic disease. Recent Pat Anticancer Drug Discov 8, 66–84, 2013.
   PubMed Web of Science ®Google Scholar
• Djamgoz MBA: Bioelectricity of cancer: voltage-gated ion channels and direct-current electric fields. In: The Physiology of Bioelectricity in Development, Tissue Regeneration, and Cancer, Pullar C (ed.). Taylor & Francis, London and New York, 2011, pp. 269–294.
   Google Scholar
• Djamgoz MBA and Isbilen B: Dietary compounds as anti-cancer agents: A preliminary evaluation of ion channels and membrane excitability as possible target mechanisms. Turk J Biochem 31, 57–68, 2006.
   Google Scholar